Geron (GERN) Other Operating Expenses (2010 - 2026)
Geron (GERN) posted Other Operating Expenses of $1.7 million for Q1 2026, down 99.13% sequentially from $193.8 million in Q4 2025, and up 40.3% YoY from $1.2 million in Q1 2025.
Geron (GERN) Other Operating Expenses (2010 - 2026) Analysis & Trends
Geron has reported Other Operating Expenses for 8 years, with the latest figure at $1.7 million in Q1 2026.
- Quarterly Other Operating Expenses rose 40.3% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $197.7 million (up 238.05% YoY) and the FY2025 annual result came in at $4.7 million, up 277.79% from the prior year.
- Other Operating Expenses fell to $1.7 million in Q1 2026 per GERN's latest filing, from $193.8 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $193.8 million in Q4 2025 and troughed at -$194.2 million in Q4 2023.
- A 4-year average of $6.9 million and a median of $1.2 million in 2025 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2024 and 2025: Other Operating Expenses jumped 194.47% in 2024, then gained 5.65% in 2025.
- Over 4 years, Other Operating Expenses stood at -$194.2 million in 2023, then surged by 194.47% to $183.4 million in 2024, then gained by 5.65% to $193.8 million in 2025, then tumbled by 99.13% to $1.7 million in 2026.
- According to Business Quant data, Other Operating Expenses over the past three periods registered $1.7 million, $193.8 million, and $1.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Geron | 1.02 Mn | -299.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.24 Mn |
| Mar 31, 2026 | 1.69 Mn |
| Dec 31, 2025 | 193.81 Mn |
| Sep 30, 2025 | 1.04 Mn |
| Jun 30, 2025 | 1.19 Mn |
| Mar 31, 2025 | 1.21 Mn |
| Dec 31, 2024 | 183.45 Mn |
| Sep 30, 2024 | 456,000.00 |
| Jun 30, 2024 | -126.62 Mn |
| Dec 31, 2023 | -194.18 Mn |
| Dec 31, 2018 | 1.46 Mn |
| Sep 30, 2013 | -84,000.00 |
| Jun 30, 2013 | -1.96 Mn |
| Dec 31, 2011 | 5.45 Mn |
| Dec 31, 2010 | 35.00 Mn |